Circulating tumour DNA for decision making in high risk and metastatic bladder cancer
2021-11-29
In this EMUC21 video interview, Prof. Dyrskjøt explains what circulating tumour DNA is and what the next steps for ctDNA-based decision-making in the clinical practice are.
